ELISA Kit Development
Research Use Only - Small Molecule Quantification
CommercialActive
Key Facts
Indication
Research Use Only - Small Molecule Quantification
Phase
Commercial
Status
Active
Company
About ImmuSmol
ImmuSmol is a specialized reagent and assay provider focusing on the challenging niche of small-molecule immunodetection. Leveraging over a decade of expertise in anti-hapten antibody development, the company offers a validated portfolio of ELISA kits and antibodies for key analytes in neuroscience, immunometabolism, and endocrinology research. Its business model is built on direct sales and a distributor network, catering primarily to the academic and biopharmaceutical research markets. The company appears to be in a revenue-generating, commercial stage with a focused product-driven strategy.
View full company profile